CY1108104T1 - (4-μεθοξυ-7-μορφολιν-4-υλο-βενζοθειαζολ-2-υλο) αμιδιο του 4-υδροξυ-4-μεθυλο-πιπεριδινο-1-καρβοξυλικου οξεος - Google Patents
(4-μεθοξυ-7-μορφολιν-4-υλο-βενζοθειαζολ-2-υλο) αμιδιο του 4-υδροξυ-4-μεθυλο-πιπεριδινο-1-καρβοξυλικου οξεοςInfo
- Publication number
- CY1108104T1 CY1108104T1 CY20081100232T CY081100232T CY1108104T1 CY 1108104 T1 CY1108104 T1 CY 1108104T1 CY 20081100232 T CY20081100232 T CY 20081100232T CY 081100232 T CY081100232 T CY 081100232T CY 1108104 T1 CY1108104 T1 CY 1108104T1
- Authority
- CY
- Cyprus
- Prior art keywords
- disease
- morpholin
- methoxy
- amide
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με την ένωση του τύπου (I): η οποία είναι το (4-μεθοξυ-7-μορφολιν-4-υλο-βενζοθειαζολ-2-υλο)-αμίδιο του 4-υδροξυ-4-μεθυλο-πιπεριδινο-1-καρβοξυλικού οξέος και με φαρμακευτικώς αποδεκτά άλατα προσθήκης οξέος αυτού. Έχει βρεθεί ότι η ένωση είναι χρήσιμη για την θεραπευτική αντιμετώπιση ή πρόληψη της νόσου Alzheimer, της νόσου Parkinson, της νόσου Huntington, της νευροπροστασίας, της σχιζοφρένειας, του άγχους, του πόνου, των προβλημάτων αναπνοής, της κατάθλιψης, της ADHD (διαταραχή ελλειμματικής προσοχής με υπερκινητικότητα), του εθισμού σε αμφεταμίνες, κοκαΐνη, οπιοειδή, αιθανόλη, νικοτίνη, κανναβινοειδή ή για την θεραπευτική αντιμετώπιση του άσθματος, αλλεργικών αντιδράσεων, υποξίας, ισχαιμίας, παροξυσμού, κατάχρησης ουσιών, ή για τη χρήση ως μυοχαλαρωτικών, αντιψυχωσικών, αντιεπιληπτικών, σπασμολυτικών και καρδιοπροστατευτικών παραγόντων.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04102262 | 2004-05-24 | ||
| EP05741185A EP1753760B1 (en) | 2004-05-24 | 2005-05-17 | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108104T1 true CY1108104T1 (el) | 2014-02-12 |
Family
ID=34967309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100232T CY1108104T1 (el) | 2004-05-24 | 2008-02-28 | (4-μεθοξυ-7-μορφολιν-4-υλο-βενζοθειαζολ-2-υλο) αμιδιο του 4-υδροξυ-4-μεθυλο-πιπεριδινο-1-καρβοξυλικου οξεος |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US7368446B2 (el) |
| EP (1) | EP1753760B1 (el) |
| JP (1) | JP4668265B2 (el) |
| CN (1) | CN1956983B (el) |
| AR (1) | AR048973A1 (el) |
| AT (1) | ATE382619T1 (el) |
| AU (1) | AU2005247567B2 (el) |
| BR (1) | BRPI0511543B1 (el) |
| CA (1) | CA2567703C (el) |
| CR (1) | CR8703A (el) |
| CY (1) | CY1108104T1 (el) |
| DE (1) | DE602005004142T2 (el) |
| DK (1) | DK1753760T3 (el) |
| DO (1) | DOP2005000091A (el) |
| EA (1) | EA011279B1 (el) |
| EC (1) | ECSP067018A (el) |
| ES (1) | ES2297710T3 (el) |
| GT (1) | GT200500124A (el) |
| HK (1) | HK1105199A1 (el) |
| HN (1) | HN2005000238A (el) |
| HR (1) | HRP20080027T3 (el) |
| IL (1) | IL179364A (el) |
| MA (1) | MA28601B1 (el) |
| MX (1) | MXPA06013417A (el) |
| MY (1) | MY140011A (el) |
| NO (1) | NO336939B1 (el) |
| NZ (1) | NZ550763A (el) |
| PA (1) | PA8633901A1 (el) |
| PE (1) | PE20060274A1 (el) |
| PL (1) | PL1753760T3 (el) |
| PT (1) | PT1753760E (el) |
| RS (1) | RS50574B (el) |
| SI (1) | SI1753760T1 (el) |
| SV (1) | SV2006002125A (el) |
| TN (1) | TNSN06371A1 (el) |
| TW (1) | TWI358297B (el) |
| UA (1) | UA87142C2 (el) |
| WO (1) | WO2005116026A1 (el) |
| ZA (1) | ZA200609136B (el) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| HUE065285T2 (hu) | 2002-12-20 | 2024-05-28 | Niconovum Ab | Nikotin-cellulóz kombináció |
| US9402809B2 (en) | 2006-03-16 | 2016-08-02 | Niconovum Usa, Inc. | Snuff composition |
| US20090082341A1 (en) * | 2007-07-23 | 2009-03-26 | Synosia Therapeutics | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER |
| PE20120008A1 (es) | 2009-01-12 | 2012-01-24 | Icagen Inc | Derivados de fenoxi bencenosulfonamida |
| US8168785B2 (en) | 2009-06-17 | 2012-05-01 | Biotie Therapies, Inc. | Benzothiazole derivatives |
| WO2011101861A1 (en) | 2010-01-29 | 2011-08-25 | Msn Laboratories Limited | Process for preparation of dpp-iv inhibitors |
| JP5872552B2 (ja) | 2010-07-09 | 2016-03-01 | ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ | 化学化合物 |
| WO2012060844A1 (en) * | 2010-11-05 | 2012-05-10 | Biotie Therapies, Inc | A2a antagonists as cognition and motor function enhancers |
| AU2013251079B2 (en) * | 2012-04-20 | 2017-03-23 | Ucb Pharma S.A. | Methods for treating Parkinson's disease |
| JP2018517785A (ja) * | 2015-06-19 | 2018-07-05 | バイオティー セラピーズ インコーポレイテッド | 制御放出トザデナント製剤 |
| WO2018059531A1 (zh) * | 2016-09-30 | 2018-04-05 | 苏州晶云药物科技有限公司 | 一种腺苷a2a受体拮抗剂药物的晶型及其制备方法和用途 |
| SG11202001337XA (en) * | 2017-08-21 | 2020-03-30 | Merck Patent Gmbh | Bezimidazole derivatives as adenosine receptor antagonists |
| KR20200043434A (ko) * | 2017-08-21 | 2020-04-27 | 메르크 파텐트 게엠베하 | 아데노신 수용체 길항제로서의 퀴녹살린 유도체 |
| WO2019141096A1 (zh) * | 2018-01-19 | 2019-07-25 | 四川科伦博泰生物医药股份有限公司 | 取代脲类化合物及其制备方法和用途 |
| US20220088024A1 (en) | 2018-12-20 | 2022-03-24 | Biotie Therapies, Inc. | Methods for treating cancer using tozadenant |
| DE102019110904B4 (de) | 2019-04-26 | 2022-01-20 | Helmholtz-Zentrum Dresden - Rossendorf E. V. | N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH505543A (de) * | 1968-11-01 | 1971-04-15 | Ciba Geigy Ag | Schädlingsbekämpfungsmittel |
| LU63457A1 (el) | 1970-07-06 | 1971-11-12 | ||
| US4028374A (en) * | 1975-11-03 | 1977-06-07 | Morton-Norwich Products, Inc. | Antibacterial thiocyanatobenzothiazoles |
| DE2656468A1 (de) | 1976-12-14 | 1978-06-15 | Boehringer Mannheim Gmbh | N-(benzthiazol-2-yl)-oxamidsaeure- derivate und verfahren zu ihrer herstellung |
| KR930005004B1 (ko) | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
| FI91859C (fi) | 1987-06-17 | 1994-08-25 | Eisai Co Ltd | Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi |
| IL90337A0 (en) | 1988-05-24 | 1989-12-15 | Pfizer | Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents |
| WO1990015801A1 (en) | 1989-06-22 | 1990-12-27 | Pfizer Inc. | Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases |
| EP0427963B1 (de) * | 1989-11-10 | 1994-03-30 | Agrolinz Agrarchemikalien Gesellschaft M.B.H. | Verfahren zur Herstellung reiner, unsymmetrisch disubstituierter Harnstoffe |
| DK0604657T3 (da) | 1992-05-21 | 2000-04-17 | Otsuka Pharma Co Ltd | Phosphonsyrediesterderivat |
| FR2753970B1 (fr) | 1996-10-01 | 1998-10-30 | Synthelabo | Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique |
| JPH11130761A (ja) | 1997-10-24 | 1999-05-18 | Otsuka Pharmaceut Co Ltd | ベンゾチアゾール誘導体 |
| CA2309319A1 (en) | 1997-11-10 | 1999-05-20 | Bristol-Myers Squibb Company | Benzothiazole protein tyrosine kinase inhibitors |
| JP2002501059A (ja) | 1998-01-23 | 2002-01-15 | ファルマシア・アンド・アップジョン・カンパニー | オキサゾリジノンの組合せライブラリー、組成物および調製方法 |
| JP2002525373A (ja) | 1998-09-30 | 2002-08-13 | ニューロゲン コーポレイション | ２−ピペラジノアルキルアミノベンゾアゾール誘導体：ドーパミン受容体サブタイプ特殊リガンド |
| GB9824579D0 (en) * | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
| UA71587C2 (uk) | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Аміди антранілової кислоти та їхнє застосування як лікарських засобів |
| IL133680A0 (en) | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| DE60023949T2 (de) | 2000-05-12 | 2006-08-10 | Corning Inc. | Verfahren zum herstellen einer vorform mit schutzumhüllung für optische fasern |
| IL153278A0 (en) * | 2000-06-21 | 2003-07-06 | Hoffmann La Roche | Benzothiazole derivatives |
| US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
| US6713499B2 (en) * | 2001-12-12 | 2004-03-30 | Hoffman-La Roche Inc. | 7-Amino-benzothiazole derivatives |
-
2005
- 2005-05-17 PL PL05741185T patent/PL1753760T3/pl unknown
- 2005-05-17 NZ NZ550763A patent/NZ550763A/en not_active IP Right Cessation
- 2005-05-17 SI SI200530160T patent/SI1753760T1/sl unknown
- 2005-05-17 EP EP05741185A patent/EP1753760B1/en active Active
- 2005-05-17 UA UAA200613530A patent/UA87142C2/ru unknown
- 2005-05-17 CN CN200580016875XA patent/CN1956983B/zh not_active Expired - Fee Related
- 2005-05-17 JP JP2007513750A patent/JP4668265B2/ja not_active Expired - Fee Related
- 2005-05-17 AU AU2005247567A patent/AU2005247567B2/en active Active
- 2005-05-17 CA CA2567703A patent/CA2567703C/en active Active
- 2005-05-17 WO PCT/EP2005/005329 patent/WO2005116026A1/en active Application Filing
- 2005-05-17 DE DE602005004142T patent/DE602005004142T2/de active Active
- 2005-05-17 MX MXPA06013417A patent/MXPA06013417A/es active IP Right Grant
- 2005-05-17 DK DK05741185T patent/DK1753760T3/da active
- 2005-05-17 PT PT05741185T patent/PT1753760E/pt unknown
- 2005-05-17 AT AT05741185T patent/ATE382619T1/de active
- 2005-05-17 ES ES05741185T patent/ES2297710T3/es active Active
- 2005-05-17 RS RSP-2008/0125A patent/RS50574B/sr unknown
- 2005-05-17 EA EA200602048A patent/EA011279B1/ru not_active IP Right Cessation
- 2005-05-17 BR BRPI0511543-4A patent/BRPI0511543B1/pt not_active IP Right Cessation
- 2005-05-18 US US11/132,019 patent/US7368446B2/en active Active
- 2005-05-20 MY MYPI20052309A patent/MY140011A/en unknown
- 2005-05-20 DO DO2005000091A patent/DOP2005000091A/es unknown
- 2005-05-20 TW TW094116495A patent/TWI358297B/zh not_active IP Right Cessation
- 2005-05-23 PE PE2005000569A patent/PE20060274A1/es active IP Right Grant
- 2005-05-23 HN HN2005000238A patent/HN2005000238A/es unknown
- 2005-05-23 PA PA20058633901A patent/PA8633901A1/es unknown
- 2005-05-23 AR ARP050102104A patent/AR048973A1/es not_active Application Discontinuation
- 2005-05-23 GT GT200500124A patent/GT200500124A/es unknown
- 2005-05-24 SV SV2005002125A patent/SV2006002125A/es unknown
-
2006
- 2006-10-24 CR CR8703A patent/CR8703A/es unknown
- 2006-11-02 ZA ZA200609136A patent/ZA200609136B/xx unknown
- 2006-11-14 TN TNP2006000371A patent/TNSN06371A1/fr unknown
- 2006-11-16 IL IL179364A patent/IL179364A/en active IP Right Grant
- 2006-11-21 EC EC2006007018A patent/ECSP067018A/es unknown
- 2006-11-22 MA MA29481A patent/MA28601B1/fr unknown
- 2006-12-12 NO NO20065732A patent/NO336939B1/no not_active IP Right Cessation
-
2007
- 2007-09-27 HK HK07110484.5A patent/HK1105199A1/xx not_active IP Right Cessation
-
2008
- 2008-01-18 HR HR20080027T patent/HRP20080027T3/xx unknown
- 2008-02-28 CY CY20081100232T patent/CY1108104T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108104T1 (el) | (4-μεθοξυ-7-μορφολιν-4-υλο-βενζοθειαζολ-2-υλο) αμιδιο του 4-υδροξυ-4-μεθυλο-πιπεριδινο-1-καρβοξυλικου οξεος | |
| ATE466858T1 (de) | 3-arylisoxazol-4-carbonylbenzofuranderivative | |
| ATE438632T1 (de) | Aryl-4-ethinylisoxazolderivate | |
| IL189762A0 (en) | Isoxazolo derivatives as gaba a alpha5 inverse agonists | |
| ATE521348T1 (de) | Kombination aus glycopyrrolat und einem beta2- adrenoceptor-agonist | |
| BRPI0510515A (pt) | compostos de morfolina | |
| BR0214221A (pt) | Derivados de benzotiazol como ligantes de receptores de adenosina | |
| ATE466007T1 (de) | 5-substituierte indol-2-carbonsäureamidderivate | |
| ATE457986T1 (de) | Benzothiazolderivate | |
| DE602004025935D1 (de) | Histondeacetylaseinhibitor und verfahren zu dessen herstellung | |
| BRPI0514820A (pt) | antagonistas de receptor de histamina-3 amina azabicìclicos | |
| MY140167A (en) | Substituted benzothiazoles | |
| JO2502B1 (en) | 4-Hydroxy-4-methyl-piperidine-1-carboxylic acid-4) methoxy-7-morpholine-4-yl-benzothiazole-2-yl) -amide | |
| ATE417039T1 (de) | 3,4-dihydro-2-naphthoesäureamidderivate und deren therapeutische anwendungen | |
| DE602005014365D1 (de) | Verfahren zur gewinnung von 2-amino-6-alkylamino-4,5,6,7-tetrahydrobenzothiazolen | |
| ATE485820T1 (de) | Verwendung von n-(dibenz (b,f)oxepin-10-ylmethyl)-n-methyl-n-prop-2-inyl min (omigapil) zur prophylaxe und/oder behandlung von muskeldystrophie | |
| ATE440826T1 (de) | Benzoxazolonderivate, verfahren zu deren herstellung und deren anwendungen | |
| DE602008005014D1 (de) | Prolinamidtetrazolderivate als nk3-rezeptorantagonisten | |
| TH98489A (th) | ไพแรซอลแอนะล็อก | |
| TH98482B (th) | เกลือซินาโฟเอตของสารประกอบ5-ออกซาโซล-2-อิล-ควิโนลีนที่ถูกแทนที่ | |
| TH98489B (th) | ไพแรซอลแอนะล็อก | |
| TH77075A (th) | ซัลฟามิคซิดอามีด | |
| TH76804A (th) | 4-ไฮดรอกซี-4-เมทธิล-ปิเปอริดีน-1-คาร์บอกซิลิกแอซิด (4-เมทธอกซี-7-มอร์โฟลิน-4-อิล-เบนโซไธเอโซล-2-อิล)-เอไมด์ | |
| TH87428B (th) | สารประกอบชนิดใหม่ | |
| DE602006018149D1 (de) | Substituierte triazolderivate und ihre verwendung als antagonisten des neurokinin-3-rezeptors |